Navigation Links
MVI and Inovio partner to develop malaria vaccines using innovative vaccine delivery tech
Date:1/7/2013
ranslate to humans," said Dr. David C. Kaslow, director of MVI. "Determining if and how these potent immune responses lead to protection against infection with the most deadly form of malaria is a high priority in our efforts to develop a next generation malaria vaccine."
The clinical study will contain two study arms. The first study arm will include three antigens, two pre-erythrocytic (CSP and TRAP) and one blood stage (AMA-1), shown previously to protect against Plasmodium falciparum, the most deadly malaria strain. The second study arm will include two additional pre-erythrocytic-stage antigens (LSA-1 and CelTOS).
Dr. J. Joseph Kim, President and CEO of Inovio, said, "We are pleased to work with MVI to advance into a human study with Inovio's plasmid DNA. Our synthetic vaccine platform has produced vaccine candidates against HPV, HIV, and influenza targets that have generated potent T cell immune responses observed in human clinical studies. Using the same platform technology, we have now generated encouraging data with preclinical testing of our malaria antigen plasmids. We are excited to work with our collaborators at MVI toward the ultimate goal of conquering malaria."
The focus on vaccines that deliver multiple antigens simultaneously is a leading approach to developing highly effective malaria vaccines. The Inovio platform is technically well suited to deliver multiple target antigens and has effectively demonstrated in preclinical studies an ability to induce potent immune responses to these antigens. This is one of a series of platforms MVI plans to evaluate for its capacity to induce immune responses that confer protection from malaria infection in the human challenge model.
The Phase 1/2a clinical trial, which will begin in early 2014, will test Inovio's plasmid DNA and electroporation technology in approximately 30 individuals, as part of what is known as a challenge trial by controlled human malaria infec
'/>"/>
| Contact: Preeti Singh psingh@burnesscommunications.com 301-280-5722 Burness Communications Contact: Bernie Hertel Contact: Jeff Richardson |
Related biology news :
1. Physiological societies partner with Wiley on new open access journal
2. Fred Hutchinson Cancer Research Center partners with GlaxoSmithKline to develop muscular dystrophy therapeutics
3. Mainz University Medical Center agrees partnership with Yale University
4. Wiley Partners with TED
5. Study details essential role of trust in agricultural biotech partnerships
6. NCH partners with Silicon Valley to market high-end diagnostic and medical research software
7. Immune system fighters speak in patterns of proteins, prefer squishy partners
8. British Ecological Society partners with Wiley open access journal Ecology and Evolution
9. Advanced Clinical Joins MedNet Solutions iMedNet Partner Program
10. Statistics & Data Corporation Selects MedNet Solutions As Strategic Technology Partner
11. CEVA, Rubidium Partner to Deliver Speech Processing Solutions based on the CEVA-TeakLite Family of DSPs
Post Your Comments:
(Date:5/18/2013)... 2013) The AGA Research Foundation is honored to ... Award in Digestive Cancer, which will support Andrew D. ... the University of Pennsylvania, Philadelphia, as he furthers his ... regeneration and cancer progression. , "The AGA Research Foundation ... two distinguished clinicians and AGA Legacy Society members," said ...
(Date:5/17/2013)... By day, insects provide the white noise of the South, ... typical year, the Southern air hangs heavy from the humidity ... to more than 140 species of frogs, toads and salamanders, ... If the ponds and swamps are the auditorium for their ... Research and Monitoring Initiative, or ARMI, have front-row seats. ...
(Date:5/17/2013)... project (Intelligent Cargo in Efficient and Sustainable Global Logistics ... an improvement in the efficiency of intermodal loading systems ... making. It comprises 29 European organisations with experience in ... has a budget totalling 17,000,000 and a duration of ... to specify and develop the semantic components and ontologies ...
Breaking Biology News(10 mins):AGA Research Foundation grant furthers digestive cancer research 2Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4New logistics services that will cut energy consumption and CO2 emissions 2... ORLANDO, Fla., June 30, 2011 Biomechanical testing of ... HULC™ exoskeleton is now underway at the U.S. Army ... Mass. The testing is expected to help shape future ... (Photo: http://photos.prnewswire.com/prnh/20110630/FL28804 ) ...
... progenitor cells may not come with a clean genetic slate ... FASEB Journal ( http://www.fasebj.org ) shows that adult stem ... change once a cell differentiates. This is important because epigenetic ... cell,s DNA, but rather, how that DNA functions. Epigenetic changes ...
... California and other premium winegrowing regions of the United ... new study led by Stanford University climate scientists. ... Research Letters , the scientists ,report that by 2040, ... grapes in high-value areas of northern California could shrink ...
Cached Biology News:Lockheed Martin's HULC™ Robotic Exoskeleton Enters Biomechanical Testing at U.S. Army Natick Soldier Systems Center 2Adult stem cells carry their own baggage: Epigenetics guides stem cell fate 2Global warming could alter the US premium wine industry in 30 years, says Stanford study 2Global warming could alter the US premium wine industry in 30 years, says Stanford study 3Global warming could alter the US premium wine industry in 30 years, says Stanford study 4(Date:5/17/2013)... rejection occurs when the transplant recipient,s immune system identifies ... It was previously thought that T cells, the immune ... molecules known as chemokines in order to migrate to ... Journal of Clinical Investigation , Fadi Lakkis and colleagues ... that chemokine stimulation of T cells is not required ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 The new ... Photonics21 at the association’s recent annual meeting drew ... EC Vice-President Neelie Kroes, who called the action “a ... and a stimulant to European innovation.” , The Board ... of the new Photonics PPP at its 29 April ...
(Date:5/17/2013)... PALO ALTO, Calif. , May 17, 2013 ... that it has achieved 50% enrollment of the ... trial to evaluate the safety and preliminary efficacy ... Progenitor Cells) therapy for Knee Osteoarthritis (KOA). To ... Effect (SAE) reported. The Phase I ...
(Date:5/17/2013)... Insero Health, Inc., a company developing natural compounds ... neurological disorders, is today reporting top-line results from a ... patients with drug-resistant epilepsy. The data are being presented ... meeting by Dr. Steven Schachter , ... Advisory Board. In this study, INS001 appeared safe and ...
Breaking Biology Technology:SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2[0] Researchers identify signals that direct the immune system to reject a transplanted organ[0] SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions[0] Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis[0] Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy
... Website Tackles Water Safety, Environmental Concerns With Test Kits, Water ... Filters and ... That is the,question. At least it is in the minds of ... aren,t sure if their tap water is,safe. Discover Testing has assembled ...
... REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, ... ), a leader in,the development of microRNA-based ... Scientist Prof. Zvi Bentwich will present AACR,s,upcoming ... Bentwich,s presentation will focus on Rosetta Genomics,unique ...
... Sept. 12 Elekta is pleased to,announce the ... Volumetric Intensity Modulated Arc Therapy (VMAT)*. The complete,offering ... the Elekta booth at,this year,s European Society of ... 2007. Performing VMAT with Elekta,enables helical- like conformality ...
Cached Biology Technology:Discover Testing Settles the Drinking Water Debate: Tap vs. Bottled 2Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference 2Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO 2Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO 3Discover Testing Settles the Drinking Water Debate: Tap vs. BottledRosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" ConferenceElekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
... NGGC3' 3'CGGN NNNNCCG5' Inactivation Conditions: Heat inactivation ... treatment followed by ethanol precipitation. Storage Conditions: ... EDTA, 1.0mM DTT, 0.01% BSA, 50% glycerol. ... Store at -20C. Unit Definition: One unit ...
...
Anti-Tissue Trans-glutaminase (IgA) EIA Sample Size: 10 l...
... Lysozyme Assay Kit (E-22013) provides,researchers with ... of lysozyme,activity in solution. This fluorescence-based ... 20 U/mL (Figure 1). The assay,measures ... which are labeled to such a ...
Biology Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |